Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Spencer

Vascular & Interventional Radiology Highlands Ranch, CO Medical Doctor

NPI 1740279504 CMS profile 169352

8671 S Quebec St Ste 200, Highlands Ranch, CO 80130

Open in the dashboard

General payments

$189,459

247 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$52,234 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Elizabeth Spencer of Highlands Ranch, CO is reported in the CMS Open Payments database as having received $189,459 across 247 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $52,234 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,315 14
2024 General $7,437 22
2023 General $15,334 35
2022 General $17,870 34
2021 General $12,247 26
2020 General $29,111 27
2019 General $98,144 89

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Spencer
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Elizabeth Spencer were reported at $9,315. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Elizabeth Spencer Vascular & Interventional Radiology median Middle half National median
2019 $98,144 $422 $125–$1,555 $163
2020 $29,111 $200 $68–$652 $114
2021 $12,247 $280 $99–$866 $132
2022 $17,870 $433 $137–$1,497 $149
2023 $15,334 $506 $152–$2,019 $160
2024 $7,437 $556 $175–$1,930 $164
2025 $9,315 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $120,068 57 payments
  2. Boston Scientific Corporation $38,065 61 payments
  3. Pfizer Inc. $8,829 26 payments
  4. Medtronic, Inc. $8,487 28 payments
  5. Bard Peripheral Vascular, Inc. $5,228 11 payments
  6. E.R. Squibb & Sons, L.L.C. $3,051 13 payments
  7. AngioDynamics, Inc. $2,731 8 payments
  8. Surmodics, Inc. $746 11 payments
  9. Shockwave Medical, Inc $434 5 payments
  10. Medtronic Vascular, Inc. $418 9 payments
  11. Other $1,402 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $84,125 28 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $65,800 24 payments
  3. Consulting Fee $24,825 16 payments
  4. Food and Beverage $8,315 155 payments
  5. Travel and Lodging $3,872 20 payments
  6. Education $1,322 3 payments
  7. Long term medical supply or device loan $1,200 1 payment
Products named General payments · program years 2019–2025
  1. IGT D Peripheral $67,444 29 payments
  2. Spectranetics Undiv $18,948 6 payments
  3. ANGIOJET $10,287 6 payments
  4. (9520) IGT Devices Undivided $10,250 4 payments
  5. ELIQUIS $8,829 26 payments
  6. US EQ Undivided $8,500 2 payments
  7. Abre $8,236 24 payments
  8. (V061) IVUS Systems $5,500 1 payment
  9. VENOVO $5,168 8 payments
  10. VENOUS WALLSTENT $5,108 3 payments
  11. Other $45,631 156 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Interventional Radiology: 38

Drug cost

$19

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tramadol Hcl Generic 12 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$168,007

Medicare's payments for the services billed

Medicare patients

135

Average age 69

Services billed

752

89 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 61%
High blood pressure 51%
Depression 30%
Ischemic heart disease 24%
Osteoporosis 21%
Cancer 15%
Chronic kidney disease 13%
COPD 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $57
$57 — —
PAXLOVID
  • PFIZER INC. $15
$15 — —
NURTEC ODT
  • PFIZER INC. $9
$9 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

247 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record